Hybrids of Coumarin Derivatives as Potent and Multifunctional Bioactive Agents: A Review
- PMID: 31038071
- DOI: 10.2174/1573406415666190416121448
Hybrids of Coumarin Derivatives as Potent and Multifunctional Bioactive Agents: A Review
Abstract
Background: Coumarins exhibit a plethora of biological activities, e.g. antiinflammatory and anti-tumor. Molecular hybridization technique has been implemented in the design of novel coumarin hybrids with several bioactive groups in order to obtain molecules with better pharmacological activity and improved pharmacokinetic profile.
Objective: Therefore, we tried to gather as many as possible biologically active coumarin hybrids referred in the literature till now, to delineate the structural characteristics in relation to the activities and to have a survey that might help the medicinal chemists to design new coumarin hybrids with drug-likeness and varied bioactivities.
Results: The biological activities of the hybrids in most of the cases were found to be different from the biological activities presented by the parent coumarins. The results showed that the hybrid molecules are more potent compared to the standard drugs used in the evaluation experiments.
Conclusion: Conjugation of coumarin with varied pharmacophore groups/druglike molecules responsible for different biological activities led to many novel hybrid molecules, with a multitarget behavior and improved pharmacokinetic properties.
Keywords: Coumarins; anti-Alzheimer; anti-inflammatories; anti-microbial; anticancer; enzymes' inhibitors; hybrids..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.Eur J Med Chem. 2022 Jan 5;227:113921. doi: 10.1016/j.ejmech.2021.113921. Epub 2021 Oct 20. Eur J Med Chem. 2022. PMID: 34715585 Review.
-
Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer.Mini Rev Med Chem. 2019;19(17):1443-1458. doi: 10.2174/1389557519666190308122509. Mini Rev Med Chem. 2019. PMID: 30854961 Review.
-
Coumarin derivatives: an updated patent review (2015-2016).Expert Opin Ther Pat. 2017 Nov;27(11):1201-1226. doi: 10.1080/13543776.2017.1360284. Epub 2017 Aug 14. Expert Opin Ther Pat. 2017. PMID: 28756713 Review.
-
Coumarin hybrids as novel therapeutic agents.Bioorg Med Chem. 2014 Aug 1;22(15):3806-14. doi: 10.1016/j.bmc.2014.05.032. Epub 2014 May 22. Bioorg Med Chem. 2014. PMID: 24934993 Review.
-
Recent Developments of Coumarin-based Hybrids in Drug Discovery.Curr Top Med Chem. 2022 Mar 4;22(4):269-283. doi: 10.2174/1568026622666220105105450. Curr Top Med Chem. 2022. PMID: 34986774 Review.
Cited by
-
Pharmacochemical Studies of Synthesized Coumarin-Isoxazole-Pyridine Hybrids.Molecules. 2025 Apr 2;30(7):1592. doi: 10.3390/molecules30071592. Molecules. 2025. PMID: 40286200 Free PMC article.
-
Trending Topics on Coumarin and Its Derivatives in 2020.Molecules. 2021 Jan 19;26(2):501. doi: 10.3390/molecules26020501. Molecules. 2021. PMID: 33477785 Free PMC article. Review.
-
Computational and biological studies of novel thiazolyl coumarin derivatives synthesized through Suzuki coupling.Turk J Chem. 2020 Dec 16;44(6):1610-1622. doi: 10.3906/kim-2005-19. eCollection 2020. Turk J Chem. 2020. PMID: 33488257 Free PMC article.
-
Design, synthesis, molecular docking study and molecular dynamics simulation of new coumarin-pyrimidine hybrid compounds having anticancer and antidiabetic activity.Med Chem Res. 2023;32(6):1143-1162. doi: 10.1007/s00044-023-03060-8. Epub 2023 Apr 21. Med Chem Res. 2023. PMID: 37305206 Free PMC article.
-
Coumarin-amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition.RSC Adv. 2024 Aug 6;14(34):24671-24686. doi: 10.1039/d4ra04226c. eCollection 2024 Aug 5. RSC Adv. 2024. PMID: 39108966 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources